# Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study

**Authors:** Franco Locatelli, Carmelo Rizzari, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Cornelia Eckert, Anja Möricke, Mary Sartor, Ondrej Hrusak, Christina Peters, Vaskar Saha, Luciana Vinti, Rajendra Desai, Michael Henry, Gerhard Zugmaier, Arend von Stackelberg

PMC · DOI: 10.1038/s41375-025-02800-6 · Leukemia · 2025-11-13

## Full-text entities

- **Diseases:** acute lymphoblastic leukemia (MESH:D054198)
- **Chemicals:** Blinatumomab (MESH:C510808)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12789001/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12789001/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12789001/full.md

---
Source: https://tomesphere.com/paper/PMC12789001